Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topiramate Augmentation in Bulimia Nervosa Partial Responders

NCT00988481 is registered in ClinicalTrials.gov with Neuropsychiatric Research Institute, Fargo, North Dakota as lead sponsor.

NCT NCT00988481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topiramate Augmentation in Bulimia Nervosa Partial Responders
Lead sponsor
Neuropsychiatric Research Institute, Fargo, North Dakota
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2009
Completion date
September 30, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bulimia nervosa